Uncategorized

The cuts will impact fewer than 20 employees, the system confirmed on Monday.

EyePoint Pharmaceuticals’ treatment for wet age-related macular degeneration showed comparable results to Regeneron’s Eylea with a less frequent dosing regimen.

The HHS’ Office of the Inspector General’s report tallied 707 criminal enforcement actions and 746 civil actions for fraud and misspent funds in programs like Medicare and Medicaid.

The health systems will jointly operate four-hospital Highpoint Health in Tennessee, though Lifepoint will retain majority ownership. 

The company expects the acquisition to be revenue accretive starting in 2024.

After gaining market share during the Philips recall, Resmed can keep growing by stimulating demand through marketing initiatives and new products, William Blair analysts wrote.

Mass.-based Seismic Therapeutic secured a new investor in Bessemer Venture Partners and $121 million in its Series B round as it looks to push its two lead candidates into the clinic.

The acquisition of the freestanding emergency departments comes after HCA announced it was investing billions to expand its emergency and high acuity service lines.

The Ohio-based health system struggled financially during its fiscal year 2022. However, rising patient demand has cut the nonprofit’s operating losses.

In the latest example of major pharma now entering AI collaborations or using AI-based tools, AstraZeneca’s deal with Absci will aim to produce an oncology candidate.